This brings the total number of oncology specialists to four, within a service comprising 12 oncology professionals.
After getting her bachelor’s degree in biology from Duke University, Sarah (pictured right) enrolled at the University of Pennsylvania School of Veterinary Medicine, from which she graduated summa cum laude (with highest honours) in 2017.
Sarah stayed on at Penn to complete an internship in small animal medicine and surgery followed by a residency in medical oncology.
She became a diplomate of the American College of Veterinary Internal Medicine in 2021 and joined the team at Davies in October 2021.
Sarah said: “I joined Davies for the opportunity to collaborate with specialists spanning all aspects of veterinary medicine.
“This allows me to provide the best care for my patients and contribute to the future of veterinary medicine.
"It is a privilege to work with so many kind, motivated and intelligent individuals that share these same goals.”
The first webinar Does Ease of Use Have to Come at the Expense of Efficacy? is presented by Claire Harrison BSc (Hons) RVN VTS (Dentistry) AFHEA, Dentistry Nurse at the Hospital for Small Animals at the Royal ‘Dick’ School of Veterinary Studies.
Claire will consider the best practice of daily toothbrushing for oral homecare and explore what practices can do to contextualise care for the many owners who struggle to achieve this goal.
Animalcare highlights research which shows that the number of pet owners who brush their pet’s teeth daily is very small: one study in Sweden suggested that only 8% of dog owners and 4% of cat owners met this target¹.
Senior Brand Manager Eleanor Workman Wright said: “With periodontal disease so common in dogs and cats, supporting owners to maintain an oral health regime for their pet is essential.
"Daily toothbrushing remains best practice but many owners are just not able to do this, so it is important to suggest effective alternatives in order to protect their pet’s oral health.
“During this webinar series dental experts will explore a range of approaches which can be used with owners & pets throughout the different stages of their pets’ lives, either as an alternative to toothbrushing, or as part of a programme to build up to toothbrushing.”
To register, visit: www.animalcare.co.uk/dentalwebinars
Further webinars in the oral homecare series will be delivered in January 2023.
Reference
Nestlé Purina is launching a new diet this month which, according to the company, helps delay the canine brain ageing process.
The diet, Pro Plan Senior 7+ Original, is enriched with medium chain triglycerides (MCTs). Research carried out by Nestlé Purina and published online in the British Journal of Nutrition (here's the abstract), apparently demonstrates improvements in senior dogs' memory, learning capacity and ability to adapt to novel situations when fed on this MCT-enriched formula.1 According to the company, the MCTs provide neurons with a readily accessible source of energy to counteract the decline in glucose metabolism that occurs naturally in ageing dogs, thus maximising brain function with demonstrable improvements in cognitive function.
Veterinary surgeon, Barton Stephen, BVM&S MRCVS, veterinary columnist for The People said: "When treating brain ageing or CCD in senior dogs I believe we vets need to adopt a more holistic approach. We can treat diseases like heart failure and kidney disease and offer advice on exercise, joint care and weight control. All of these can improve quality of life and encourage a pain free existence, but until now we have had nothing proven to help dogs stay younger for longer. This innovative new dog food has the added advantage of staving off cognitive decline which owners find very distressing."
For more information on Pro Plan Senior 7+ Original and the Pro Plan, diet range, please contact your Veterinary Business Development Manager or contact Nestlé Purina PetCare, telephone: 0800 212 161 (Freephone)
Reference:¹ Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. British Journal of Nutrition (Pan et al 2010)
Ceva Animal Health, maker of the veterinary behaviour products DAP and Feliway, is once again sponsoring the Association of Pet Behaviour Counsellors' series of one day behaviour seminars to keep veterinary professionals up-to-date with companion animal behavioural issues.
Featuring presentations by top pet behaviourists, the seminars will cover a range of topics based on questions that pet owners frequently ask veterinary professionals in practice.
Contributing to six hours CPD per event, the topics covered in the seminars are:
Places on the seminars cost from £70. For further information, please contact the APBC on 01386 751151 or visit http://www.apbc.org.uk/
Eclipse Veterinary Software has released a new mobile addition to its equine veterinary practice management system.
Eclipse Mobile allows veterinary surgeons to access up-to-date clinical information wherever it is needed, be that on the yard, at the practice, or while making field visits.
When Eclipse Mobile is offline, all the information the vet needs is stored on the device. When next connected via 3G or Wi-Fi, any new details are sent to and from the practice - syncing notes made by the vet, adding follow-on appointments and To Do messages, services delivered and products administered to keep everyone up-to-date throughout the day.
Whilst online, client payments can be taken via debit/ credit cards within the app and detailed drug batch information recorded using the iPad/iPhone's camera as a barcode scanner, if required.
Jeanne Razzell, CEO of Eclipse said: "Many of the vets we work with have been keen to carry animal histories with them on visits, including the latest lab test results, together with recent clinical notes, and diagnostic imaging, e.g. x-rays, ultrasounds and MRI, CT or bone scans. Now, with Eclipse Mobile, every vet can have all of this information at their fingertips automatically - at every appointment; both in the consult room and on the road."
Eclipse Mobile is available for iPad, iPad mini, iPhone, Android smart phones/tablets and Microsoft Windows Surface
For more information, contact Jeanne Razzell, CEO, Eclipse Veterinary Software Limited, on +44 (0)1799 532988 or +44 (0)7515 906466. Website: www.eclipsesoftware.info
Davies Veterinary Specialists (DVS), the private small animal referral centre based in Hertfordshire, has installed two new state-of-the-art ESAOTE ultrasound machines.
DVS says The MyLab Twice Vet and the MyLab Class C Vet provide fast, efficient and highly accurate imaging in a wide range of applications, including high-definition abdominal, cardiac, musculoskeletal and ophthalmic scans.
The MyLab Twice Vet, with its range of probes including the broadband 18MHz linear probe, will be used for general ultrasonographic imaging at DVS. It is capable of the most refined contrast media examinations that, for example, can help to locate and identify a liver tumour that may be rendered invisible when using conventional diagnostic procedures.
The MyLab Class C will be used predominantly for advanced cardiac work, including trans-oesophageal echocardiography for interventional procedures in theatre.
Pedro Oliveira, European Veterinary Specialist in Cardiology at DVS said: "The trans-oesophageal probe is currently a very rare piece of equipment in veterinary diagnostics. It gives us the capacity to obtain unique views of the heart, especially the heart base which can be a very difficult area to examine with regular echocardiography. It also allows real-time and direct monitoring of procedures, such as deployment of devices to occlude patent ductus arteriosus, surgery and anaesthesia in critical patients."
The first patient to benefit from the new My Lab Class C was an 11-year-old, female German shepherd dog with suspected cardiac neoplasia following several episodes of haemorrhage into the pericardium. A normal echocardiographic examination identified a small suspect area but it was in a part of the heart that was very difficult to approach surgically.
However, a trans-oesophageal examination revealed that another small mass close to the tip of the right auricle was actually the origin of the bleeding. The dog underwent surgery to remove the mass and subsequently made a full recovery. Without the My Lab Class C there would have been no viable options for this dog.
Clive Elwood, Managing Director at DVS, said: "Combining the best possible on-site diagnostic equipment with some of Europe's finest clinicians enables us to provide the best possible service and outcome for our patients, across multiple disciplines."
Vet Futures, the joint initiative by the RCVS and the BVA to help the profession prepare for and shape its own future, has revealed the results of a survey which found that 59% of veterinary surgeons are optimistic about the future of the profession. 600 vets took part in the survey, which explored vets' attitudes towards their profession, and asked them to prioritise the key issues and rank some of the major threats and opportunities for the profession.Reducing stress was the single most important goal for the future, with 19% of respondents choosing it from a long list of options.The BVA and the RCVS say that priority goals for veterinary surgeons varied according to different areas of work and seniority in the profession. However, an overriding and uniting theme from the findings was the pursuit of recognition for the role vets play across the board. Vets' perception of the veterinary contribution to non-clinical roles, such as research, food supply and security, and public health, is high, but they don't believe the general public values these roles.Four of the respondents' top five goals for 2030 related to recognition:
Looking at how vets are respected and valued by society, Vet Futures points to its national ICM opinion poll of more than 2,000 members of the public which found that 94% of the general public trusts the veterinary profession generally or completely.
In terms of their own careers, 59% of vets said they felt that they had met or exceeded their expectations, leaving 41% saying their careers had only met some expectations (38%) or not met any (3%). Amongst this large minority of dissatisfied vets the reasons for their responses included: few opportunities for progression, pay, and working hours.The survey also asked vets to rank threats and opportunities for the profession and found that respondents considered the three greatest opportunities to be:
BVA President John Blackwell said: "It's heartening to see that, at the moment, the veterinary glass is half full for many. But we know that younger vets are disproportionately represented amongst those who are feeling less positive about their own careers, which is a real concern for future generations. There is clearly work to be done, through Vet Futures, for the profession to think innovatively in order to tackle some of their concerns around career progression, pay and working hours, as well as stress."The good news is that, through the Vet Futures UK-wide roadshow and our online engagement, we have been hearing new and interesting ideas for the future. We want to hear from as many vets, vet nurses and others who have a stake in the future of the profession and I would encourage people to get involved through our 'Veterinary Vision' essay competition or via the Vet Futures website."RCVS President Stuart Reid added: "There is a lot for the veterinary profession to be proud of but the Vet Futures survey shows that vets are concerned the general public doesn't understand or value the variety of roles we undertake outside clinical practice."We have also heard through our guest blog that vets working outside of practice sometimes feel that they are treated as second-class vets. "Through the Vet Futures project RCVS and BVA aim to address the lack of public awareness about the variety of roles undertaken by members of the profession, as well as increase understanding and access to these varied career opportunities amongst the profession. "We want to enable all veterinary surgeons to not only feel optimistic, but confident in their future."
The Worldwide Veterinary Service, the charity founded by Luke Gamble MRCVS to support animal welfare charities globally, is celebrating a donation of products including dog and cat wormers, skin and joint supplements and NSAIDs, by Ceva Animal Health.
The donated products were dispatched to the WVS’s own centres and shelters in Thailand, including its 'Care for Dogs' shelter in Chiang Mai, Thailand, as well as to over 60 animal welfare charities around the world, all of which have registered a wish list of items to the WVS.
One of the charities that benefited from the company's donation of over 1,000 Milbactor worming tablets to the WVS was the Liberia Animal Welfare and Conservation Society (LAWCS). Dogs are often kept in horrendous conditions in Liberia and LAWCS provides responsible dog ownership education, free veterinary care and treatment and community outreach feeding programmes to pet owners. The WVS’s donation helped enable LAWCS to reach and provide free veterinary care and treatment to 420 dogs in the country.
Luke Gamble, chief executive and founder of WVS, said: "The donation from Ceva is fantastic and we can’t thank the company enough. Its support means so much to the charity and enables us to help animals in tough places where veterinary support is hard to find. Ceva has always supported WVS and its generosity in giving us another donation like this is simply amazing."
Cuneyt Seckin, managing director at Ceva Animal Health said: "Our donation to WVS helps charities and organisations whose veterinary resources can be scarce or extremely difficult to fund improve the welfare conditions of animals that are often kept in horrendous conditions.
"Treatments like wormers are the most requested items by WVS’s associated charities, so we are delighted that our donation has been able to impact the welfare of individual animals to greatly improve their quality of life."
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
The Royal College of Veterinary Surgeons Trust's Adopt-A-Book campaign has raised almost £17k in sponsorship to pay for the restoration of books in the historical collection.
The latest book to be restored under the scheme is a nineteenth century edition of Every man his own farrier, by F. Clater, which has been restored thanks to veterinary surgeon Fiona Dalzell.
Fiona said: "I have always loved books, and especially old books, but I got inspired by the Adopt-a-Book scheme when I came to the RCVS for a meeting of the Veterinary History Society".
These editions, she says, are "works of art in their own right," and it has given her a "huge amount of pleasure to know that you can do so much just from a small donation."
RCVS Trust Director Cherry Bushell explained the idea behind a campaign: "When you think of 'adoption', you may more readily recall the rescue animals treated in veterinary practices than old books. However, these old books also need your help - and are an important part of the veterinary heritage that the Trust seeks to preserve."
Restoring a book can cost between £25 and £250, and adopted books carry a book-plate naming their benefactor. They can also be dedicated 'in memoriam'.
Since its inception six years ago, the Adopt-a-Book campaign has raised £16, 851, and funded the restoration of 139 volumes:
Those interested in supporting this work by adopting a book can view available titles at www.rcvs.org.uk/adoptabook or contact Clare Boulton, RCVS Trust Librarian (c.boulton@rcvstrust.org.uk or 020 7202 0752).
The RCVS Charitable Trust is offering up to 10 grants worth around £500 each, to support UK veterinary surgeons looking to pursue themes of clinical or non-clinical research involving short-term visits to veterinary or medical centres, or research institutes, outside the UK.
The Travel Awards are open to registered members of the RCVS, as well as to candidates registered for a PhD at a UK veterinary school. The awards are available for up to 12 months from the award date, and awards cannot be made for projects taking place before 31 October 2011.
The successful candidates will be asked to submit an article to the veterinary press and provide the Trust with a diary record including photographs, and/or short video.
All applications must be received by 5pm on Monday 31 October 2011.
Further information including full application criteria, is available from www.rcvstrust.org.uk/grants/
Alternative, contact grants@rcvstrust.org.uk or call 0207 202 0741.
Academics from the University of Bristol's School of Veterinary Sciences and the neurology team at Southmead Hospital Bristol have published the results of study examining the use of percutaneous electrical nerve stimulation (PENS) therapy as a treatment for headshaking syndrome in horses.
The authors say that the condition, a neuropathic facial pain syndrome, often leaves affected horses impossible to ride and dangerous to handle, and can result in euthanasia. At present there are no consistently safe and effective methods for the treatment of headshaking in horses, and the condition is estimated to affect between 10,000 and 20,000 horses in the UK.
The study, which is published in the Equine Veterinary Journal (EVJ), aimed to discover whether PENS therapy, developed by Algotec Research and Development Ltd, is safe, effective and sustainable for the management of trigeminal-mediated headshaking in horses.
Seven horses diagnosed with trigeminal-mediated headshaking were recruited to the trial. All procedures were carried out in sedated horses with a needle-prick sized area of skin desensitised with local anaesthetic to help probe insertion. A disposable PENS probe was placed just beneath the skin adjacent to the nerve under ultrasonographic guidance. The nerve was stimulated for 25 minutes following a protocol of alternating frequencies and a perception threshold based on human clinical data. The probe was removed and the procedure repeated on the other side. Three or four treatments were used during the protocol, with treatments being repeated when signs of headshaking recurred.
All horses tolerated the procedure well. Three horses developed a haematoma at the site on one occasion and two had increased clinical signs for up to three days following first treatment. Six horses responded well after the first treatment and returned to ridden work at the same level before headshaking began. Five horses continued to respond to further treatment.
Veronica Roberts, Senior Clinical Fellow in Equine Medicine in the University's School of Veterinary Sciences, who led the study, said: "Headshaking in horses is a major welfare issue and can be a significant cause of distress.
"Although it is clear that further work is required, including increasing the number of cases and refining the treatment procedures, the study shows that PENS therapy should be the first-line treatment for trigeminal-mediated headshakers, which have failed to respond to conservative treatment, such as nose-nets."
The role was created last November when the Animal & Plant Health Agency (APHA) started allowing para-professional staff to support vets in carrying out TB testing in England.
UK Farmcare says there are now 49 fully authorised ATTs in England with another 21 TB testing under veterinary supervision and three undergoing the theory part of the training.
To become an ATT, applicants must be at least 18 years old, hold a valid UK driving licence and passport, possess a clean criminal record and then be approved by the APHA. Applicants also need at least three graded GCSEs or equivalent in English, Maths and a science or food production subject and at least six months cattle handling experience.
https://ukfarmcare.com/an-introduction-to-the-att-role.
The videos were primarily created to support veterinary treatment in light of the conflict in Ukraine, but VetCT says they are also useful for UK veterinary professionals dealing with natural disasters such as flooding and fires.
The videos were created by VetCT Emergency and Critical Care specialists with special interest and expertise in trauma in conflict zones, including Dr Erin Mays, an Officer in the US Army Veterinary Corps, and Dr Guillaume Hoareau (pictured right), whose PhD in collaboration with the US Air Force focussed on resuscitation and haemorrhage control.
Victoria Johnson, VetCT Director, said: “As a global teleconsulting and teleradiology company we are incredibly fortunate to have some exceptional expertise in a broad range of clinical areas.
"The response to our call within our team for production of videos that will help support the treatment and welfare of animals caught up in natural or man-made disasters was outstanding.
"We are delighted to be able to offer this expert training free of charge and hope it proves helpful to many of our colleagues working hard to help the people and pets of Ukraine and beyond.”
VetCT is encouraging colleagues to share the videos within the veterinary profession globally to help veterinary teams involved in treating trauma in animals.
To watch the films, visit: https://www.vet-ct.com/gb/news/2022/may/11/free-trauma-training/
Viewers are invited to make a voluntary donation to the Disasters Emergency Committee (DEC) charity to support humanitarian aid efforts globally here: https://www.justgiving.com/fundraising/vetct-trauma-training.
—ENDS—
Photo Caption 1: Victoria Johnson, VetCT Founder and Director
Photo Caption 2: Trauma training videos QR link
The association says that its research has found that 94% of companion animal vets say they have clients who feed a raw diet, 42% who feed meat-free diets and 29% who feed insect-protein in place of meat.
However, 6 in 10 vets are unsure how many of the cats and dogs they see are fed meat-free diets.
In a new policy position, the BVA is now urging vets to talk to all cat and dog owners about what they feed their pet, and record nutritional histories and any resulting issues on their practice systems.
BVA President Anna Judson said: “We know that owners of cats and dogs are increasingly drawn to pet diets that reflect their own personal values and lifestyle choices, and this is leading to a surge in alternative approaches to pet food.
"We support owners making informed choices about what to feed their pets, but they must be aware that these choices play a pivotal role in the health of the animal and can also have a wider impact on human health and environmental sustainability.
“One of the key issues in these conversations is the lack of long-term, evidence-based research.
"If vet teams are to maintain our position as the ‘trusted voice’ in these conversations, it’s vital that we ask the right questions and also record as much data as possible so that we can understand the long-term impact of some of these newer diets.”
The BVA says its new policy position is not trying to dictate the ‘best’ diet for individual pets but to support pet owners in meeting their pets’ nutritional needs as well as meeting their own lifestyle choices.
The BVA is also recommending changes to veterinary education to include a new emphasis on the importance of nutrition in day one competencies for vets and nurses, and improved awareness of the need for supportive conversations with animal owners.
To support the profession, the BVA says it will create a new public facing resource and lobby for better labelling of pet food and better labelling and traceability of the animal by-products that represent one of the major sources of protein in many cat and dog foods.
Anna added: “The issues around pet food are complex and with so much information available to pet owners from breeders, friends, online forums and other sources, we want to support all members of the vet team to feel fully confident in guiding their clients through dietary decisions.
"We hope that these recommendations and our upcoming resources will improve the information available to both clients and vets, supporting owners to make healthy, informed choices for their pets.”
https://www.bva.co.uk/take-action/our-policies/diet-choices-for-cats-and-dogs
Lohmann Animal Health has launched AviPro IBD Xtreme vaccine against Infectious Bursal Disease — also known as Gumboro Disease — in broilers, commercial layers and breeders.
According to Lohmannn, it is highly effective against the vvIBDV (very virulent IBD virus), it breaks through high levels of maternal antibodies, and controls mortality with no loss of flock performance.
Since the 1980s the acute form of IBD has caused significant economic loss to the poultry industries in several countries. The vvIBDV, a more aggressive form first described in Europe in 1986, is now widespread throughout the world and can cause losses of 30-60 per cent in layers and 5-25 per cent in broilers.
Chicks are most susceptible between one and six weeks. Early in their lives they are protected by maternally-derived antibodies (MDAs), but these antibodies will neutralise live IBD vaccines when they are given too early. However, being highly invasive, the AviPro IBD Xtreme vaccine is able to overcome these MDAs so can be given earlier to provide greater protection from an early age.
Exact timing of vaccination depends primarily on the level of MDAs and the breakthrough titre of the vaccine on the one hand, and the virulence of the field virus and infection pressure on the other.
When compared with four of its main competitors in a trial with SPF birds AviPro IBD Xtreme outperformed them. It had the highest number of sero-positive birds, the highest mean ELISA-antibody titre seven days after vaccination and the best protection against clinical symptoms and mortality after a challenge with vvIBDV,” commented Brigitte Othmar, regulatory affairs manager at LAH.
“With the addition of AviPro IBD Xtreme, Lohmann Animal Health has now completed its range of live IBD vaccines and is able to provide its customers with the appropriate solution for any Gumboro problem,” she added.
AviPro IBD Xtreme can be applied via the drinking water or eye-drop and is presented in vials of 1,000 and 2,500 doses.
More information on this vaccine can be found on the Lohmann Animal Health website http://www.lah.de/.
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two and four way break tablets facilitate ease of use and should improve compliance. The company also highlights the affordability of the new product, which can be used alone or in conjunction with standard therapies.
According to Alstoe, it is estimated that in 75% of dogs with CHF, degenerative mitral valve disease is the underlying cause. The company says spironolactone shows clear benefits in treating mxyomatous mitral valve disease (MMVD) in dogs: acting as an aldosterone receptor antagonist it counteracts the negative consequences of aldosterone production such as myocardial fibrosis and myocardial and vascular remodelling.
To support the new product, Alstoe has designed a Sleep Respiratory Rate (SRR) chart to assist veterinary professionals with ongoing monitoring of their canine patients condition and response to treatment. The chart is available as a printable download or in pads. The company is also offering lunchtime practice seminars.
Tempora is available as 10mg, 50mg and 100mg tablets.
For further information, contact Alstoe Animal Health on 01347 878606, or via e-mail: adelaideellerington@alstoe.co.uk, or visit www.alstoe.co.uk
A new study published this month in the Equine Veterinary Journal (EVJ)1 has concluded that toxins from the seeds of the sycamore tree (Acer pseudoplatanus) are the likely cause of Atypical Myopathy (AM) in Europe.
However, to avoid confusion, the authors of the study point out that the American Sycamore (also just called 'the sycamore' in the USA), is a completely different species: Platanus occidentalis. Furthermore, the sycamore found in the UK is also known as the sycamore maple in other countries.
The new research follows on the heels of a study in the USA earlier this year that linked toxins from the box elder tree (Acer negundo) with Seasonal Pasture Myopathy (SPM), the US equivalent of AM2. The discovery marks an important step for the future prevention of this fatal disease.
Atypical Myopathy is a highly fatal muscle disease in the UK and Northern Europe. In ten years, approximately twenty European countries have reported the disease. Incidences tend to occur repeatedly in the autumn and in the spring following large autumnal outbreaks. Horses that develop AM are usually kept in sparse pastures with an accumulation of dead leaves, dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed. SPM is a very similar disorder, prevalent in Midwestern USA and Eastern Canada that is now known to be caused by the ingestion of hypoglycin A, contained in seeds from the box elder tree.
The new European research1 was conducted by an international team led by Dominic Votion, University of Liege and involved 17 horses from Belgium, Germany and The Netherlands, suffering from Atypical Myopathy. High concentrations of a toxic metabolite of hypoglycin A, were identified in the serum of all of the horses. The pastures of 12 of the horses were visited by experienced botanists and the Acer pseudoplatanus, the sycamore maple, was found to be present in every case. This was the only tree common to all visited pastures.
Researchers believe hypoglycin A is the likely cause of both AM in Europe and SPM in North America. The sycamore and the box elder are known to produce seeds containing hypoglycin A and the pastures of the afflicted horses in Europe and the USA were surrounded by these trees.
Hypoglycin-A is found in various levels in the seeds of plants in the genus Acer as well as in various other genera in the family Sapindaceae such as ackee (Blighia sapida). In ackee, hypoglycin-A levels do vary with ripeness of the fruit and, if the fruit is eaten before it is mature, it causes hypoglycaemia to different degrees including a condition called "Jamaican vomiting sickness" (because of ackee's use in Jamaican cooking) and occasionally death in humans.
Researchers at the Universities of Minnesota2 and Liege are continuing their work to try to uncover exactly how the equine disease occurs. Dr Adrian Hegeman of University of Minnesota said: "It is likely that the most important contributing factors to horses becoming poisoned by hypoglycin-A are the availability of seed in the field combined with lack of other feeding options. The seeds from two species of maples (box elder and sycamore maples) that we have tested include significant quantities of hypoglycin-A.
"We know that seeds contain highly variable quantities from seed to seed, even within a single tree. We do not know yet how hypoglycin-A levels vary seasonally, nor do we know how its abundance varies with different levels of stress to the plant, though this may well explain seasonal variability in the occurrence of the malady. It is possible that conditions that stress the plants may contribute to significant seasonal changes in hypoglycin-A levels. At this point we just don't know. It is common held knowledge that trees under stress usually produce more seed."
Dr Jeff Gillman of University of Minnesota said: "Without question, further analysis of the seeds and other tissues from Acer species needs to be performed along with sampling of plant materials over multiple seasons and at various stress levels. Additionally, one cannot rule out more complex explanations for the seasonality of disease occurrence such as: animals may begin feeding on seed materials in response to depletion of more palatable choices under drought conditions; or simple explanations such as high wind events driving seeds into fields. These sorts of explanations for the occurrence of the disease do not depend on botanical variations in toxicity across seasons, sites or stress levels, yet also require consideration.
"Although limited examples are available, the experience of animals at a pasture site might also confer some degree of behavioral resistance to poisoning due to exposure at sub-lethal levels with prior exposure to seeds in the pasture."
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is an important advancement in our understanding of what causes AM and how it can be prevented. In immediate practical terms owners can take prompt measures to avoid exposing their horses to sycamore seeds this autumn. Where horses are grazing in the vicinity of sycamore trees, it is imperative that they are provided with sufficient supplementary feed as this will minimise the risk that horses might be tempted to ingest seeds containing this toxin. This must be done carefully and leaving wet hay on the ground should be avoided so providing extra carbohydrate feeds may be more practical."
References
Virbac has announced that it is running Canine Prostate Awareness Month (CPAM) in November, or 'Movember' as it's called by those fundraising for male prostate disease and testicular cancer.
With more than 80% of entire male dogs over the age of five suffering from Benign Prostatic Hyperplasia (BPH)1, the aim of the initiative is to highlight the prevalence of the disease and to encourage practices and owners to check for and seek treatment for it.
As part of Canine Prostate Awareness Month, Virbac is providing participating practices with promotional materials including owner educational and display materials, postcards, an email/text message service, a template press release for local media and free branded slip leads for owners who get their dog checked during the promotion.
Sarah Walker BVM&S CertAVP MRCVS, Product Manager (Companion Animal), at Virbac, said: "CPAM aims to remind owners that men are not the only ones to suffer from prostate disorders. It's a well-supported initiative and, running it at a time when the media spotlight is already on the dangers of prostate cancer in men, means we can spread the message that owners should also be monitoring dogs for signs of prostate disease."
In the run up to the campaign, the company is highlighting OdelisTM CPSE, the first ELISA test to screen for, diagnose and monitor BPH, which is available from three UK diagnostic laboratories. Virbac says it is a cost-effective, precise and reliable alternative to rectal palpation. In addition, Virbac makes Ypozane, a tablet treatment for BPH, which it claims is effective within one week and last for six months.
Sarah added: "The problem with BPH is that the majority of dogs suffer in silence. It is a painful condition that too often goes unnoticed until it reaches an advanced stage, where the owner notices blood in the urine or painful urination.
"We're providing practices with all the materials they need to promote the campaign locally and hope those involved will find it effective in terms of bringing clients into the practice for advice on BPH. We've also organised coverage in national dog magazines to drive clients to practices."
For further information on CPAM, email cpam@virbac.co.uk; contact your Virbac Territory Manager or call the company direct on 01359 243243.
Last year's event generated an impressive amount of media coverage about ticks on Radio Four's Today programme, BBC Radio 1, 2 and 5, BBC TV Breakfast, BBC TV News, Good Morning Britain, ITV News and Channel 5 news, amongst others, providing an opportunity for practices to convert heightened public awareness into more protected pets.
Amanda Melvin, Small Animal Marketing Manager at MSD Animal Health said: "Last year’s Tick Awareness Month was a great success thanks to the high involvement of veterinary practices. We would like to give as many practices as possible the chance to get involved this year so are urging surgeries to get in touch early and we will ensure you get a pack of support resources for this nationwide event."
For further information, contact your MSD Animal Health representative or visit: www.bigtickproject.co.uk.
The term ‘evidence synthesis’ describes a range of methodological approaches used to systematically review, appraise, and summarise evidence on a specific area.
The approaches differ from conventional literature reviews or narrative reviews, which are not required to have a specified search strategy or methodology for appraising evidence, and usually present a personal perspective or opinion.
There are three main types of evidence syntheses: rapid reviews, systematic reviews, and scoping reviews.
All have key principles in common, which includes the formulation of a structured question, a systematic search of the available literature, a defined process of reviewing and selecting suitable publications, and a methodology for analysing the final included evidence.
Evidence synthesis is still not widely used in the equine veterinary world, despite its recognised value in human evidence-based medicine.
In the new virtual collection, the EVJ discusses the what and the why of this important evaluation method, as well as providing free access to all the equine veterinary evidence reviews published to date, including:
“Evidence synthesis makes an important contribution towards generating the evidence base which underpins equine clinical practice,” said Professor Sarah Freeman. “The challenge compared to human medicine is that equine veterinary data sets are much smaller, and study approaches and methodologies often vary significantly which means that it may not be possible to combine or collate data sets.
“Given this shortfall, scoping reviews can be helpful to identify what information is out there, find areas where a systematic review could be performed, and provide a useful summary for all the studies in a particular area.”
Professor Celia Marr, Editor of the EVJ said: “As increasing numbers of evidence syntheses are published, they will expand our understanding of the current bodies of evidence in veterinary medicine.
“The existing studies are already informing us on how we use evidence in our practices and policies, and it is encouraging to anticipate how they will shape our development of future research, to generate the best evidence as the norm, in every case.”
The virtual issue can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.evidence-synthesis-collection
The Horserace Betting Levy Board (HBLB) has launched an online version of the Codes of Practice on equine diseases, ready for the 2011 Thoroughbred breeding season.
The website, codes.hblb.org.uk is a replica of the 2011 booklet, but with an easy to use navigator and built-in text search.
The 2011 online Codes of Practice set out minimum recommendations for the prevention and control of disease. Applying to all breeds of horse and pony, and to both natural mating and AI, the Codes cover:
The increasing mobility of horses creates a subsequent increased risk of spreading infectious disease. In recent years, most countries with active horse populations have seen incidents of these diseases, including in Britain the notifiable diseases of CEM, EIA and EVA.
Any of these diseases can have serious consequences for horse and pony breeding, compromising welfare, disrupting breeding activity and causing economic loss and distress.
Professor Willie Donachie, Chairman of the HBLB's Veterinary Advisory Committee said: "We recognise the changing ways in which vets, studs and individual breeder's access information. The new online version of the Codes is designed to reflect this and ensure that the Codes of Practice, a vital resource, are available where and when they are needed."
Novartis Animal Health has launched Farming against BVD, a new initiative to help in the fight against Bovine Viral Diarrhoea (BVD).
The campaign, which is being carried out in partnership with key industry bodies, will begin with an independent survey of farmers, the results of which will be announced in April.
An expert panel, headed by Professor Joe Brownlie (Royal Veterinary College and Chairman of the BVD Scientific and technical working group), will then come together to analyse the findings, using them to shape and drive an industry response.
Professor Brownlie said: "BVD is a costly and complex disease, spread by a pestivirus that affects the reproductive and immune systems. Persistently Infected (PI) animals are the main source of infection, but can be hard to identify without testing. Only total eradication will prevent the disease from spreading. Eradication Schemes in a number of European countries have already succeeded and Scotland and Ireland have embarked on similar schemes. The information being gathered will help the industry to develop a much needed scheme for England and Wales."
Joining Professor Joe Brownlie on the expert panel will be Dr Peter Nettleton (Moredun Research Institute), Mansel Raymond (dairy farmer and Chairman of the NFU Dairy Board), Caroline Dawson (Novartis Animal Health veterinary surgeon) and Paddy Gordon (veterinary practitioner).
Survey topics will include levels, and methods, of testing for BVD on farm, understanding of the role of PI animals and the financial impact of BVD on dairy and beef units. Farmers will also be asked who they look to for advice and how they view the role of vaccination.
Caroline Dawson MRCVS from Novartis Animal Health said: "Countrywide eradication may not be achieved for a number of years, although individual farmers can control the disease on their own farms within 1-2 years, providing substantial cost benefits. The purpose of this campaign is to encourage farmers to take action now against BVD. By working closely with their vets, identifying and removing PI animals, BVD can be removed. Ensuring adequate biosecurity and a robust vaccination policy will eliminate the risk of bringing BVD back onto the farm."
Professor Brownlie said: "Understanding what farmers understand about BVD, particularly the role of the PI animal, will enable members of the panel and the wider industry, including Novartis and the BVD Stakeholder Group, to meet farmer needs more accurately. Greater awareness of the problem is vital - this is the only way that progress towards eradication will be made."
The project looked first at how effective CVS small animal first opinion practices were at conducting echocardiography.
It found that a barrier to wider uptake was a lack of up-to-date equipment, along with a lack of current knowledge and training - both in using ultrasound and echocardiography equipment and in interpreting images.
CVS says that as a result, many colleagues were routinely referring suspected cardiac disease cases.
The project leaders then reviewed and recommended practice equipment, so that clinicians had the tools to perform echocardiograms in practice.
This included buying echocardiography tables - so that practitioners could scan an animal’s chest from underneath, more advanced cardiac ultrasound machines and electrocardiogram (ECG) machines.
The company then produced a range of resources for vets and nurses, to help them to improve echocardiography scan rates and nurse cardiology clinics, including clinical guidelines, machine guides and client resources.
It then held a number of training sessions for its vets and nurses, focusing on the latest advancements in heart disease diagnosis and treatment for vets, and training nurses how to conduct nurse cardiology clinics, how to perform and interpret electrocardiography, how to take blood pressure readings and thoracic point of care ultrasound (POCUS).
Lynsay Morgan, Regional Clinical Lead at CVS who is responsible for the cardiac ultrasound clinical improvement project, said: “We want to empower our first opinion small animal vets to perform more echo evaluations and to work up their cardiology cases to a high standard.
"We also want our nurses to be involved in patients’ life-long care, and provide ongoing support to owners of pets with heart disease.
“We hope this project will improve case identification, increase skills and confidence, and see optimum diagnosis and management of cardiac disease.”
The Dogs Trust has officially launched the Free Microchipping Through Vets Campaign through which all owners can get their dog microchipped free of charge through participating veterinary practices.
Microchipping becomes compulsory for all dogs in England in April 2016 and Wales in March 2015, and with 20% of dogs in the UK still unchipped, the charity says it thinks demand for the procedure is likely to be significant over the coming year.
1500 practices have already joined the year-long campaign, as part of which they will be given free microchips in exchange for implanting them at no cost to the owner. The charity says it hopes that up to 75% of the UK's 3075 practices will have joined the campaign within the next few weeks.
Clarissa Baldwin, Chief Executive of Dogs Trust, said: "We are delighted about the proposed new legislation and see it as the start of a very positive movement. From April 2016 in England and March 2015 in Wales it will be compulsory for each and every dog to be microchipped on first change of hands which represents a significant step forward for dog welfare and responsible dog ownership. To show its support for the implementation of this legislation, Dogs Trust is teaming up with vets to make sure that all dog owners can have the procedure done for free. We'd like to say a huge thank you to the vet practices already supporting the campaign and urge others to come on board. An essential element to the success of microchipping is for dog owners to take responsibility for updating their details with the database should their circumstances change.
"Last year 111,986 stray and abandoned dogs were picked up by Local Authorities across the UK, with only 40% reunited with their owners. This initiative will help to reduce that number dramatically."
To join the campaign vet practices should contact Dogs Trust at campaigns@dogstrust.org.uk